I love a stock that people hate for reasons that have nothing to do with the stock.

We've seen it so many times before and I promise that we'll see it again.

These days the most amount of anger is being pointed towards Trump Media.

Dig this:

• People hate the company
• People hate the Trump
• People hate SPACs

This checks off all 3 boxes.

I love that!

In today’s Daily Digest, we’ll review:

1. No new positions today.
2. Adjustment to XLB position.
3. No exits since the last report.
4. Current status of open campaigns.

Let’s dig in!

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today's list comes via two Form 4 filings by James Gorman, executive chairman of Morgan Stanley and director of The Walt Disney Company $DIS.

Gorman bought 20,000 DIS shares, equivalent to $2.1 million.

In yesterday's note we talked about the lack of progress in most U.S. Stocks and Indexes over the past several months.

It's been a frustrating market for some traders.

That's why we've been doing this instead.

Look at the Median stock right now, stuck at the exact same price it was way back in December.

We're now in May:

From the Desk of Steve Strazza @Sstrazza

We love our bottoms-up scans here at All Star Charts. We tend to get really creative when making new universes as we want to be sure they will deliver us the best opportunities the market has to offer.

However, when it comes to our latest project, it couldn't be any simpler!

With the goal of finding more bullish setups, we have decided to expand one of our favorite scans and broaden our regular coverage of the largest US stocks.

Welcome to The Junior Hall of Famers.

This scan is composed of the next 150 largest stocks by market cap, those that come after the top 150 and are thus covered by the Hall of Famers universe. Many of these names will someday graduate and join our original Hall Of Famers list. The idea here is to catch these big trends as early on as possible.

There is no need to overcomplicate things. Market cap is a quality filter at the end of the day. It only grows if price is rising. That's good enough for us.

In today’s Options Jam Session, I revealed my itchy feeling that stocks are on the cusp of “popping” higher. Looking at charts of $SPY and $QQQ and $WFC has me thinking that there’s a pile of tinder just waiting for a spark to ignite.

What will be the trigger that gets this wildfire in motion? I don’t know.

But I’m positioned for it with a good variety of sector, time frame, geographical, and time frame exposure.

Click through to see me review many of our open positions that are likely just getting a head start on the coming breakout…

From the Desk of Alfonso Depablos @AlfCharts

As equity markets continue to repair the damage from April’s correction, we continue to find more and more stocks -- and groups of stocks -- that we want to be buying.

A growing number of those groups are coming from the financial sector. 

Financials have made a comeback in the last week as a handful of financial indexes and individual issues are reclaiming their prior-cycle highs.

The relative trends are improving as well, with the large cap sector SPDR $XLF hitting new 52-week highs versus the S&P 500 recently.

When we think about the strongest stocks within financials, asset management and capital market stocks are top of mind.

In today’s post, we will dive in and outline some of our favorite charts in the space.

Before we do that, here’s the SPDR S&P Capital Markets ETF $KCE pressing against its former highs from 2021:

Every week, we create a Power Rankings table that lists the market-cap rank of the top 20 cryptocurrencies. This allows us to see the winners and losers as they climb the market-cap ladder.

Regardless of our feelings about the man behind the phenomenon, putting that all aside, there is a potentially great trade setting up in this Trump Media & Technology Group $DJT.

I'll skip the preamble and get right to it.

In today’s Daily Digest, we’ll review:

1. New position in GLD.
2. No adjustments are needed today.
3. Exited IBB at profit target.
4. Current status of open campaigns.

Let’s dig in!

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today's list comes via two Form 4 filings by Cormorant Asset Management.

The hedge fund reported a purchase of roughly $10 million in EyePoint Pharmaceuticals $EYPT.